EPIVIR-HBV Reviews (LAMIVUDINE)Average Rating: 4.0 (3 Ratings)Filter ResultsCompare EPIVIR-HBV with similar:
Type: Rx Drug
|
Results are sorted by Date added. Key to Ratings: 1=LOW (I would not recommend taking this medicine.) Page: 1 |
RATING | REASON | SIDE EFFECTS FOR EPIVIR-HBV | COMMENTS | SEX | AGE | DURATION/ DOSAGE | DATE ADDED |
3 | Chronic HBV | No side effects | Developed lamivudine-resistant HBV (YMDD) after only 8 months. I am Genotype C, eAG positive, but confirmed precore mutant by testing. | M | 38 | 12 months | 1/7/2008 | 5 | M | 29 | 7 months | 4/1/2005 | 4 | hepatitis B | first 3 month light headache, next 6 months malaise/fatigue, 6th to 9th month hair loss, terrible nails | easy to take-just one pill a day, but without insurance pricey | F | 35 | 9 months | 1/31/2005 |
EPIVIR-HBV (LAMIVUDINE): Lamivudine-HBV is used to treat hepatitis B infection. It is not a cure for hepatitis B and does not prevent the passing of hepatitis B to others. This medication is a nucleoside reverse transcriptase inhibitor (NRTI) that works by slowing the growth of the virus, thereby decreasing liver damage caused by the virus. FDA Approval Date: 1998-12-08 (Sources: U.S. Centers for Medicare Services, FDA)